INNOVATIVE GRANTS ON IMMUNE TOLERANCE:  ADDENDUM TO RFA-AI-00-006

Release Date:  July 31, 2000

NOTICE:  AI-00-007

National Institute of Allergy and Infectious Diseases
National Institute of Diabetes, Digestive and Kidney Diseases
National Heart, Lung, and Blood Institute

The Request for Applications (RFA) entitled  INNOVATIVE GRANTS ON IMMUNE 
TOLERANCE  (AI-00-006), issued by the National Institute of Allergy and 
Infectious Diseases (NIAID) and the National Institute of Diabetes, 
Digestive and Kidney Diseases (NIDDK) in the NIH Guide on February 9, 
2000, has been amended to include the National Heart, Lung, and Blood 
Institute (NHLBI) as a co--sponsor.  NHLBI will provide $0.5 million in 
FY2001, to fund approximately 2 applications relevant to its mission.  
Studies related to allogeneic hematopoietic stem cell transplantation 
are of particular interest to NHLBI.

If you have any questions about the requirements of this RFA, please 
contact any of the following program officials:

Helen Quill, Ph.D.
Division of Allergy, Immunology, and Transplantation
National Institute of Allergy and Infectious Diseases
6700--B Rockledge Dr., Room 5140
Bethesda, MD 20892--7640
Telephone: (301) 496--7551
FAX: (301) 402--2571
Email: [email protected]

LeeAnn Jensen, Ph.D.
Division of Blood Diseases Program and Resources
National Heart, Lung, and Blood Institute
6701 Rockledge Drive, MSC 7950
Bethesda, MD 20892--7950
Telephone: (301) 435--0066
FAX: (301) 480--0868
Email: [email protected]

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

			Department of Health and Human Services (HHS)
NIH... Turning Discovery Into Health®